Membre Annuaire

Professeurs invités

BONELLA Sara
Physics department, University Rome 1 "La Sapienza"
MIRKIN Michael
Queens College - Department of chemistry and Biochemistry - New York - USA
HALLE Bertil
Université de Lund - Suède
Liste
Accueil Publications

Publications

Found 41 results

Filtres: Auteur est Lacombe, C.  [Réinitialiser tous les filtres]
2010
Chapuis, N, Lacombe C, Tamburini J, Bouscary D, Mayeux P.  2010.  Insulin Receptor A and IGF-1R in AML - Letter. Cancer Research. 70(17):7010-7010.
Chapuis, N, Tamburini J, Green AS, Willems L, Bardet V, Park S, Lacombe C, Mayeux P, Bouscary D.  2010.  Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies. Leukemia. 24(10):1686-1699. Abstract
Chapuis, N, Tamburini J, Green AS, Vignon C, Bardet V, Neyret A, Pannetier M, Willems L, Park S, Macone A et al..  2010.  Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia. Clinical Cancer Research. 16(22):5424-5435. Abstract
Chapuis, N, Park S, Leotoing L, Tamburini J, Verdier F, Bardet V, Green AS, Willems L, Agou F, Ifrah N et al..  2010.  I kappa B kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia. Blood. 116(20):4240-4250. Abstract
Green, AS, Chapuis N, Maciel TT, Willems L, Lambert M, Arnoult C, Boyer O, Bardet V, Park S, Foretz M et al..  2010.  The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. Blood. 116(20):4262-4273. Abstract
Kosmider, O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B, Hunault-Berger M, Slama B, Vey N, Lacombe C et al..  2010.  Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia. 24(5):1094-1096.
Park, S, Chapuis N, Tamburini J, Bardet V, Cornillet-Lefebvre P, Willems L, Green A, Mayeux P, Lacombe C, Bouscary D.  2010.  Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica-the Hematology Journal. 95(5):819-828. Abstract
Chapuis, N, Tamburini J, Cornillet-Lefebvre P, Gillot L, Bardet V, Willems L, Park S, Green AS, Ifrah N, Dreyfus F et al..  2010.  Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Haematologica-the Hematology Journal. 95(3):415-423. Abstract
Bardet, V, Green A, Vergez F, Tamburini J, Gallay N, Gaillard B, Pannetier M, Neyret A, Chapuis N, Ifrah N et al..  2010.  A HIGH AMOUNT OF CD34(+) CD38LOW/NEG CD123(+) CELLS HAS AN ADVERSE IMPACT ON DISEASE FREE AND OVERALL SURVIVAL IN AML PATIENTS TREATED BY INTENSIVE CHEMOTHERAPY. Haematologica-the Hematology Journal. 95:0042.
Chapuis, N, Park S, Leotoing L, Tamburini J, Verdier F, Bardet V, Green A, Willems L, Agou F, Ifrah N et al..  2010.  I-B KINASE OVERCOMES PI3K/AKT AND ERK/MAPK TO CONTROL FOXO3A ACTIVITY IN ACUTE MYELOID LEUKEMIA. Haematologica-the Hematology Journal. 95:0058.
Willems, L, Chapuis N, Green A, Bardet V, Jacque N, Park S, Ifrah N, Dreyfus F, Guichard S, Mayeux P et al..  2010.  Targeted inhibition of mtor by azd8055 blocks protein translation and has anti-leukemic activity in acute myeloid leukemia. Haematologica-the Hematology Journal. 95:0044.
Lewin, M, Arrive L, Lacombe C, Vignaud A, Azizi L, Raynal M, Jomaah N, Monnier-Cholley L, Tubiana JM, Menu Y.  2010.  Diffusion-weighted MR imaging of liver pathology: principles and cinical applications. Journal De Radiologie. 91(1):11-26. Abstract
Herrmann, E, Popovic MB, Von der Weid N, Sajadi A, Rilliet B, Lacombe C, Letenneur G, Pica A.  2010.  PEDIATRIC CRANIOSPINAL AXIS IRRADIATION WITH HELICAL TOMOTHERAPY PRELIMINARY RESULTS. Strahlentherapie Und Onkologie. 186(12):725-725.
Forejtnikova, H, Vieillevoye M, Zermati Y, Lambert M, Pellegrino RM, Guihard S, Gaudry M, Camaschella C, Lacombe C, Roetto A et al..  2010.  Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood. 116(24):5357-5367. Abstract
Barlesi, F, Balleyguier C, Besse B, Bonodeau F, Brenac F, Comeloup O, Dansin E, Ferretti G, Gaubert JY, Gervais R et al..  2010.  Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors. Annals of Oncology. 21(8):1682-1686. Abstract
Desport, E, Abraham J, Marin B, Bender S, Lacombe C, Yagoubi F, Lavergne D, Bridoux F, Jaccard A.  2010.  Hepatocyte growth factor (HGF) measurement in AL amyloidosis. Amyloid-Journal of Protein Folding Disorders. 17:189-190.
Bridoux, F, Tennent GA, Delbes S, Desport E, Lacombe C, Kalopissis A, Rowczenio D, Boimard M, Goujon JM, Touchard G et al..  2010.  The p.A1a154fsX47 ApoAI frameshift variant is a novel disulfide-linked ApoAI. Amyloid-Journal of Protein Folding Disorders. 17:118-119.
Sirac, C, Bender S, Bridoux F, Jaccard A, Lacombe C, Touchard G, Cogne M.  2010.  Strategies to modelise AL amyloidosis in mouse. Amyloid-Journal of Protein Folding Disorders. 17:116-116.
Moumas, E, Desport E, Lacombe C, Gombert JM, Goujon JM, Bridoux F, Touchard G.  2010.  Systemic AL amyloidosis with renal involvement in a region of Western France. Amyloid-Journal of Protein Folding Disorders. 17:151-151.
Alexandrova, O, Saur J, Lacombe C, Mangeney A, Schwartz SJ, Mitchell J, Grappin R, Robert P.  2010.  Solar wind turbulent spectrum from MHD to electron scales. Twelfth International Solar Wind Conference. 1216:144-147. Abstract
2009
Ugurluer, G, Ballerini G, Letenneur G, Lacombe C, Pissaturo O, Matzinger O, Montemurro M, Zouhair A, Mirimanoff RO, Ozsahin M.  2009.  Helical tomotherapy (HT) for the treatment of anal canal cancer: preliminary clinical results, and dosimetric comparison between HT and intensity-modulated or 3D conformal radiotherapy. Ejc Supplements. 7(2):331-331.
Joanne, P, Falord M, Chesneau O, Lacombe C, Castano S, Desbat B, Auvynet C, Nicolas P, Msadek T, El Amri C.  2009.  Comparative Study of Two Plasticins: Specificity, Interfacial Behavior, and Bactericidal Activity. Biochemistry. 48(40):9372-9383. Abstract
Kosmider, O, Gelsi-Boyer V, Cheok M, Grabar S, Della-Valle V, Picard F, Viguie F, Quesnel B, Beyne-Rauzy O, Solary E et al..  2009.  TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Blood. 114(15):3285-3291. Abstract
Alexandrova, O, Saur J, Lacombe C, Mangeney A, Mitchell J, Schwartz SJ, Robert P.  2009.  Universality of Solar-Wind Turbulent Spectrum from MHD to Electron Scales. Physical Review Letters. 103(16) Abstract
Auvynet, C, Joanne P, Bourdais J, Nicolas P, Lacombe C, Rosenstein Y.  2009.  Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities. Febs Journal. 276(22):6773-6786. Abstract